Hematology TimesDrug gets priority review as CLL treatmentJanuary 13, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesFDA approves rapid-infusion bendamustineDecember 11, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesFDA grants KTE-C19 breakthrough designationDecember 10, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesMixing warfarin, sulfonylurea may cause serious eventsDecember 9, 2015ThrombosisPharmacy
Hematology TimesCancer drug prices vary widely from country to countryDecember 7, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
Hematology TimesFDA approves generic imatinibDecember 6, 2015CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
Hematology TimesEC grants conditional approval for blinatumomabNovember 27, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesTrial of ofatumumab in FL stopped earlyNovember 25, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaFollicular Lymphoma
